APA aipamena

Schiff, J. P., Cotogno, P., Feibus, A., Steinwald, P., Ledet, E., Lewis, B., & Sartor, O. (2019). Early prostate-specific antigen response post-abiraterone as predictor of overall survival in metastatic castrate-resistant prostate cancer. BMC Cancer.

Chicago Style aipamena

Schiff, Joshua P., Patrick Cotogno, Allison Feibus, Peter Steinwald, Elisa Ledet, Brian Lewis, and Oliver Sartor. "Early Prostate-specific Antigen Response Post-abiraterone As Predictor of Overall Survival in Metastatic Castrate-resistant Prostate Cancer." BMC Cancer 2019.

MLA aipamena

Schiff, Joshua P., et al. "Early Prostate-specific Antigen Response Post-abiraterone As Predictor of Overall Survival in Metastatic Castrate-resistant Prostate Cancer." BMC Cancer 2019.